27 June 2023 - AGM statement

The AIM-listed medical instruments group has issued a positive trading update to coincide with its AGM.  The strong demand seen in the UK in 2022 has continued into 2023 despite the industrial action seen in the NHS.  In overseas markets, Japan and Europe have performed better than the previous year, although the US and India have been slower to pick up.  However, further investment in sales and marketing should help drive activity in the second half.  The group has a strong order book which provides some security over prospects and also underpins the group . . .

This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.

Already a member, log in HERE.

Tagged: